Home›Stock Screener›Omkar Pharmachem

Omkar Pharmachem Share Price Today | Stock Price & Omkar Pharmachem Share Screener

OMKARPH Chemicals & Petrochemicals
Live Share Price BSE
₹7.16
▲ 0.33 (4.83%)
2026-11-18 00:00:00

As of November 18, 2026, the live Omkar Pharmachem share price (BSE: OMKARPH) is ₹7.16, up 4.83% from the previous close, with shares trading between ₹7.16 and ₹7.16 in today's trading session, and a 52-week range of ₹5.66–₹29.74. Track Omkar Pharmachem market cap to gauge the company's total market size. Use the Omkar Pharmachem stock screener below to analyse P/E ratio, market cap, quarterly results, and more. See at what price today Omkar Pharmachem opened, then compare its market price and price volume with top gainers and top losers on the exchange. Record your trades in TickJournal's free trading journal and track your portfolio performance.

Key Statistics and Valuation Ratios

Omkar Pharmachem Market Cap ₹6.60 Cr.
OMKARPH P/E Ratio (TTM) -
Omkar Pharmachem P/B Ratio 0.17
EPS (TTM) ₹0.12
Dividend Yield -
Debt to Equity -
OMKARPH 52 Week High ₹29.74
Omkar Pharmachem 52 Week Low ₹5.66
Operating Margin -
Profit Margin -
OMKARPH Revenue (TTM) -
EBITDA -
Net Income -
Total Assets ₹37.00
Total Equity ₹37.00

Omkar Pharmachem Share Price Chart

Track the current stock price of Omkar Pharmachem with an interactive chart. Analyse OMKARPH share price trends, closing price, trading volume, historical performance, and volatility using live market data across different timeframes, from the last 30 days to the full record — the complete Omkar Pharmachem stock quote in one place.

The quote of ₹7.16 sits between the 52-week low of ₹5.66 and the 52-week high of ₹29.74, and the latest session moved 4.83% from the previous close.

Omkar Pharmachem Company Profile - Fundamental Screener

Screen Omkar Pharmachem company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for OMKARPH shares across the equity market and its stock price history, plus the wider market trend.

The company is classified under the Chemicals sector and the Chemicals & Petrochemicals industry, and it trades under ISIN INE501C01015.

Company Details

Classification

Sector Chemicals
Industry Chemicals & Petrochemicals
Sub-Sector Chemicals & Petrochemicals
Segment E

Identifiers and Leadership

ISIN INE501C01015

Omkar Pharmachem Balance Sheet Screener

Screen OMKARPH balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics, then compare equity shares and the debt-to-equity rate against peers in the stock market.

For 2026, total assets were ₹37, up from ₹10 in 2025.

Latest statistics put total assets at ₹37 and shareholder funds at ₹37.

Item 2026 2025 2024 2023 2022 2021 2020 2019 2018 2017

Assets

Total Assets 37 10 10 10 10 10 9 9 9 9
Current Assets 0 0 0 0 0 0 0 0 0 0
Fixed Assets 0 0 0 0 0 0 0 0 0 0

Liabilities

Total Liabilities 0 0 0 0 0 0 0 0 0 0
Current Liabilities 0 0 0 0 0 0 0 0 0 0
Non-Current Liabilities 0 0 0 0 0 0 0 0 0 0

Shareholders' Equity

Total Equity 37 9 9 9 9 9 8 9 9 9
Share Capital 10 10 10 10 10 10 10 10 10 10
Reserves & Surplus 27 -1 -1 -1 -1 -1 -2 -1 -1 -1

Omkar Pharmachem Income Statement Screener - Profit & Revenue Analysis

Screen Omkar Pharmachem income statement and profit fundamentals. Analyze OMKARPH quarterly results. Omkar Pharmachem reports revenue growth, EBITDA, net profit margins, and EPS, and TickJournal's fundamental screener helps with stock evaluation and equity returns.

For None-None, revenue was ₹0 and net profit was ₹0.

In that period expenses were ₹0, interest cost ₹0 and tax ₹0. The next period listed, 2026-March, shows revenue of ₹1 and net profit of ₹0.

Item None-None 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March 2016-March 2015-March

Revenue and Expenses

Revenue 0 1 1 1 1 1 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0 0

Operating Costs and Margins

EBITDA 0 0 0 0 0 0 0 0 0 0 0 0 0
Operating Profit % 0.00% 35.00% 54.00% 52.00% 58.00% 50.00% 8.00% -454.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0 0

Profit and Earnings

Profit Before Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0 0
Net Profit 0 0 0 0 0 0 0 0 0 0 0 0 0
EPS 0.00 0.12 0.02 0.19 0.20 0.18 0.22 -0.26 -0.42 -0.25 0.22 -0.12 -0.06

Omkar Pharmachem Cash Flow Screener - Liquidity Fundamentals

Screen OMKARPH cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength and price trend assessment against the wider stock market and other stocks.

In 2026-March, operating activities generated ₹0.

Over the same period, investing activities provided ₹0 and financing activities provided ₹0.

Item 2026-March 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March 2017-March

Cash from Operations and Investing

Operating Activities 0 0 0 0 0 0 0 0 0 -1
Investing Activities 0 0 0 0 0 0 0 0 0 1

Financing and Net Cash

Financing Activities 0 0 0 0 0 0 0 0 0 0
Net Cash Flow 0 0 0 0 0 0 0 0 0 0

Omkar Pharmachem Shareholding Pattern Screener

See Omkar Pharmachem shareholding pattern with promoter, FII, and DII holdings. Check Omkar Pharmachem promoter holding and ownership changes for OMKARPH on TickJournal, and see how institutional stock price moves affect the market.

In 2026-Mar, promoters held 0.03%, foreign institutions 0.00%, domestic institutions 0.00% and the public 98.36%, spread across 3,617 shareholders.

The shareholder count was 3,617 in 2026-Mar, compared with 3,669 in 2026-Jun.

Item 2026-Mar 2026-Jun 2026-Sept 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar

Promoter Holding

Promoter Holding 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03% 0.03%

Institutional Investors

FII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
DII Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Government, Public and Others

Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 98.36% 98.36% 98.34% 98.36% 98.36% 98.36% 98.36% 98.36%
Other Holding 1.61% 1.61% 1.63% 1.61% 1.61% 1.61% 1.61% 1.61%
Shareholder Count 3,617 3,669 3,861 3,611 3,619 3,618 3,618 3,601

Dividend Yield Screener - Share Price & Share Analysis

Check the dividend history with payout and yield data. View dividend details including ex-dates, the dividend rate, and amounts paid by Omkar Pharmachem. Omkar Pharmachem dividend yield can be compared with peers and other stocks in the market.

No dividends declared by Omkar Pharmachem.

Omkar Pharmachem Stock Index Membership - Nifty & Sensex

See which indices include Omkar Pharmachem stock. Check OMKARPH index membership in NIFTY 50, SENSEX, and other indices on TickJournal, and compare the Nifty trend with the broader market trend.

Complete Index List

Omkar Pharmachem is not part of any tracked indices.
Only major market indices are tracked in our system.

Omkar Pharmachem Market Events Screener - Corporate Actions

Get Omkar Pharmachem corporate actions including splits, bonuses, and buybacks disclosed to the exchange. Check Omkar Pharmachem stock events that may affect OMKARPH share price, along with derivatives, futures and options activity and sector gainers.

12 corporate actions are listed, the most recent entry being Quarterly Result Announcement dated November 14, 2026, with a record date of November 14, 2026.

It is followed by Annual General Meeting dated September 30, 2026 and Quarterly Result Announcement dated August 13, 2026.

Announcement Date Record Date Event Type Information Price Impact
2026-11-14 2026-11-14 Quarterly Result Announcement NA -0.64%
2026-09-30 2026-09-30 Annual General Meeting NA -8.98%
2026-08-13 2026-08-13 Quarterly Result Announcement NA -10.41%
2026-05-30 2026-05-30 Quarterly Result Announcement NA 0.00%
2026-02-14 2026-02-14 Quarterly Result Announcement NA 0.00%
2025-11-14 2025-11-14 Quarterly Result Announcement NA 0.00%
2025-09-24 2025-09-24 Annual General Meeting NA 4.48%
2025-08-13 2025-08-13 Quarterly Result Announcement NA 0.00%
2025-05-29 2025-05-29 Quarterly Result Announcement NA -6.67%
2025-02-14 2025-02-14 Quarterly Result Announcement NA 0.00%
2024-11-12 2024-11-12 Quarterly Result Announcement NA 4.97%
2024-09-30 2024-09-30 Annual General Meeting NA 0.00%

Omkar Pharmachem Competitors Screener - Peer Stocks Comparison

Screen OMKARPH competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance, from valuation and price target to the future price outlook, for better stock selection in a changing stock market.

The comparison table covers 10 companies in the Chemicals sector, shown with market capitalisation, P/E ratio, revenue, growth, net profit and RSI.

Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Solar Industries 170,302 74.20 9,966 30.94% 1,737 44.89
Pidilite Industries 157,344 57.30 14,867 11.05% 2,471 53.93
SRF 73,424 32.10 15,894 7.20% 1,835 54.24
Linde 58,944 118.20 2,549 -0.17% 549 70.98
Gujarat Fluorochemicals 52,993 78.30 5,126 5.63% 574 63.06
Navin Fluorine International 50,728 56.50 3,379 41.21% 664 72.16
Himadri Speciality Chemical 27,633 32.90 4,832 3.60% 755 40.00
Deepak Nitrite 21,753 20.50 7,947 -5.01% 551 55.44
Aether Industries 21,664 89.20 1,181 34.17% 220 53.10
Aarti Industries 17,205 29.50 8,291 13.78% 419 55.19

Omkar Pharmachem Company Announcements - News & Reports Screener

Screen OMKARPH latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis, and review the option chain for related stocks. Compare other stocks in the same sector.

20 recent announcements are listed, the latest dated .

The next most recent announcements are dated November 17, 2026 and November 17, 2026.

Date Update Actions
Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-11-17 Unaudited Financial Results Of The Company Along With Statement Of Assets And Liabilities Cash Flow Statement And Limited Review Report For The Quarter And Half Year Ended On 30 September 2026. -
2026-11-17 Board Meeting Outcome for Outcome Of Board Meeting Held On 14.11.2026 -
2026-11-04 Board Meeting Intimation for Intimation Of The Board Meeting Of The Company Under Regulation 29(1)(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-10-12 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -
2026-10-01 Shareholder Meeting / Postal Ballot-Scrutinizers Report -
2026-09-30 Shareholder Meeting / Postal Ballot-Outcome of AGM -
2026-09-26 Closure of Trading Window -
2026-09-17 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-03 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-09-02 Corporate Action-Fixes Record Date For 31St AGM -
2026-09-02 Reg. 34 (1) Annual Report. -
2026-09-02 Shareholders Meeting-AGM-September 30 2026 -
2026-08-31 Board Meeting Outcome for Outcome Of The Board Meeting Held On 31St August 2026 -
2026-08-14 Announcement under Regulation 30 (LODR)-Newspaper Publication -
2026-08-13 Unaudited Financial Results For The Quarter Ended On 30.06.2026 -
2026-08-13 Board Meeting Outcome for Outcome Of The Board Meeting Held On 13.08.2026 -
2026-08-06 Board Meeting Intimation for Intimation Of The Board Meeting Of The Company Under Regulation 29(1)(A) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 -
2026-07-18 Newspaper Publication Regarding Special Window -
2026-07-13 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 -

Frequently Asked Questions

How is the company valued right now?

The current quote is ₹7.16, within a 52-week range of ₹5.66 to ₹29.74. The P/B ratio is 0.17. Market capitalisation stands at ₹6.60 Cr. The company operates in the Chemicals sector, in the Chemicals & Petrochemicals industry, so compare these ratios with its sector peers in the table above.

About This Data

Quotes are sourced from the BSE. Key statistics were last updated on November 19, 2026. This page covers 10 balance sheet periods, 13 income statement periods, 10 cash flow years and 8 shareholding periods. Information is provided for research and is not investment advice.